USA to impose a 100% tariff on manufacturers, except firms construct crops on website, says Trump

Regal of pharmaceutical products.

D3Sign | Moment | Getty pictures

President Donald Trump announced on Thursday that the United States will impose a 100% tariff “any brand or patented pharmaceutical product” on October 1.

The measure does not apply to companies that build drug manufacturing systems in the USA, said Trump.

He added that the exception covers projects where the construction started, including locations that have broken the ground or are under construction.

“There will therefore be no tariff for these pharmaceutical products when the construction has started,” said Trump in a post about the social truth.

Brand or patented pharmaceutical products are drugs that are sold under trade names and are protected by patents or other intellectual property that block the general competition until these protective measures are expired.

The announcement came when Trump also unveiled a service of 25% for heavy trucks and a delivery of 50% for “all kitchen cupboards, bathroom washbasins and associated products”, which will also begin on October 1st.

In August, Trump told CNBC’s “Squawk Box” that planned tariffs for pharmaceuticals imported in the USA could finally reach up to 250%, the highest rate that he has threatened so far.

He said he would initially impose pharmaceuticals a “small tariff”, but then “maximum” in one to one and a half year, he will increase this rate to 150% and then to 250%.

The new tasks are followed by the introduction of Fresh National Security Investigations, which were announced on Wednesday in importing robotics, industrial machines and medical devices.

The most recent probes of the Ministry of Commerce are expanding the list of goods that are faced with higher tariffs to include personal protective equipment such as surgical masks, N95 -ate protection devices, gloves and other medical consumption materials, including injections and needles.

“Pharmaceuticals such as prescription drugs, over -the -counter drugs, biologicals and special medication are not covered in this study, since these imports are examined in a separate examination of § 232,” said the trade department.

All new tasks that result from the sector -specific probes would be stacked by Trump’s country -specific tariffs, although the European Union and Japan have made agreements that they could protect against additional taxes.